Company Encyclopedia
View More
name
UNI HEALTH
02211.HK
Universal Health International Group Holding Limited, an investment holding company, distributes and retails drugs and other pharmaceutical products in the northeastern region of the People’s Republic of China. It offers Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, disinfection products, blood products, medical equipment, prepackaged food, health care products, nutritional food, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; and dairy products, including infant formula milk powder. The company also provides storage services. The company was formerly known as Jintian Pharmaceutical Group Limited and changed its name to Universal Health International Group Holding Limited in July 2015.
178.78 B
02211.HKMarket value -Rank by Market Cap -/-

Financial Score

20/11/2025 Update
C
Health Care DistributorsIndustry
Industry Ranking14/20
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-7.76%D
    • Profit Margin-3.66%D
    • Gross Margin15.94%D
  • Growth ScoreE
    • Revenue YoY-34.57%E
    • Net Profit YoY-6406.38%E
    • Total Assets YoY-34.20%E
    • Net Assets YoY-8.33%D
  • Cash ScoreE
    • Cash Flow Margin-2735.94%E
    • OCF YoY-34.57%E
  • Operating ScoreA
    • Turnover1.25A
  • Debt ScoreB
    • Gearing Ratio29.05%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    "Performance" UNI HEALTH reported a full-year loss of 26.01 million RMB, turning from profit to loss

    UNI HEALTH announced its financial results for the fiscal year ending in June, with revenue of 712 million RMB, a year-on-year decrease of 34.7%. It recorded a loss of 26.01 million RMB, compared to a net profit of 410,000 RMB in the previous year, turning from profit to loss; the loss per share was 32.46 cents. No dividend was declared

    AASTOCKS·
    HK
    02211
    0.00%
    AASTOCKS·
    HK
    02211
    0.00%

    UNI HEALTH announced its annual performance, with a loss attributable to shareholders of 26.06 million yuan, turning from profit to loss year-on-year

    UNI HEALTH announced its annual performance for the year ending June 30, 2025, with revenue of approximately 711.5 million yuan, a year-on-year decrease of 34.7%; gross profit of approximately 113.4 million yuan, a year-on-year decrease of 37%; and a loss attributable to shareholders of 26.06 million yuan, a shift from profit to loss year-on-year, with a loss per share of 32.46 cents. The decline in revenue was mainly due to the impact of the new national medical insurance policy and a decrease in the number of active customers within the national distribution network

    Zhitong·
    HK
    02211
    0.00%
    Zhitong·
    HK
    02211
    0.00%

    "Profit Warning" UNI HEALTH forecasts an annual loss of at least 25.7 million RMB

    UNI HEALTH issued a profit warning, expecting a net loss of no less than 25.7 million RMB for the fiscal year ending in June, compared to a net profit of 600,000 RMB in the previous year. The loss is mainly due to the recognition of subsidiary income from the previous year

    AASTOCKS·
    HK
    02211
    0.00%
    AASTOCKS·
    HK
    02211
    0.00%

    UNI HEALTH issues a profit warning, expecting an annual net loss of no less than 25.7 million yuan, a year-on-year loss reversal

    According to the Zhitong Finance APP, UNI HEALTH announced that the group expects to incur a net loss of no less than RMB 25.7 million for the current year (ending June 30, 2025), while it recorded a net profit of approximately RMB 600,000 for the year ending June 30, 2024. As understood by the board of directors, the transition from net profit to net loss is primarily attributed to the recognition of gains from the sale of subsidiaries in the profit and loss statement for the year ending June 30, 2024

    Zhitong·
    HK
    02211
    0.00%
    Zhitong·
    HK
    02211
    0.00%

    On September 18th, UNI HEALTH completed the issuance of approximately 30.4403 million subscription shares

    According to the Zhitong Finance APP, UNI HEALTH announced that it completed the issuance of approximately 30.4403 million subscription shares on September 18, 2025, with an issue price of HKD 0.8 per share

    Zhitong·
    HK
    02211
    0.00%
    Zhitong·
    HK
    02211
    0.00%